Yapei Zhang is a Boston, Massachusetts based female Ophthalmologist who is specialized in Ophthalmology. Active license number of Yapei Zhang is 1018767 for Ophthalmology in Massachusetts. Yapei Zhang is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Yapei Zhang speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Female
Practice Address:
243 Charles St, Boston, Massachusetts, 02114-3096
Phone:
617-573-3689
Fax:
617-573-6965
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1477172674
NPI Enumeration Date:
09 Apr, 2020
NPI Last Update On:
01 Jul, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Yapei Zhang are as mentioned below.
License Number
Specialization
State
Status
1018767
Ophthalmology
Massachusetts
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
243 Charles St, Boston, Massachusetts
Zip:
02114-3002
Phone Number:
617-523-7900
Fax Number:
--
Patients can reach Yapei Zhang at 243 Charles St, Boston, Massachusetts or can call to book an appointment on 617-573-3689. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.